Enhanced bioavailability of soy isoflavones by complexation with β-cyclodextrin in rats

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 12, 2007, Pages 2927-2933

  Lee, Seung Hyun ^a   Kim, Young Heui ^a   Yu, Heui Jong ^a   Cho, Nam Suk ^a   Kim, Tae Hyun ^a   Kim, Dong Chool ^b   Chung, Chan Bok ^c   Hwang, Yong Il ^c   Kim, Ki Ho ^a  

^a Bioland Ltd   (South Korea)

^b Chungnam National University   (South Korea)

^c Kyungnam University   (South Korea)

Author keywords

cyclodextrin; Bioavailability; Complexation; Isoflavone

Indexed keywords

AQUEOUS SOLUBILITY; GLYCITEIN; ISOFLAVONE GLYCOSIDE;

ABSORPTION; BIOACTIVITY; COMPLEXATION; LIVING SYSTEMS STUDIES; OXYGEN;

CYCLODEXTRINS;

BETA CYCLODEXTRIN DERIVATIVE; DAIDZEIN; GENISTEIN; GLYCITIN; ISOFLAVONE DERIVATIVE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; MALE; ORAL DRUG ADMINISTRATION; RAT; SOYBEAN; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; GENISTEIN; ISOFLAVONES; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS;

RATTUS;

EID: 37649024104     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70296     Document Type: Article

References (33)

1. Ososki, A. L., and Kennelly, E. J., Phytoestrogens: a reveiew of the present state of research. Phytother. Res., 17, 845-869 (2003).
2. Albertazzi, P., and Purdie, D. W., The nature and utility of the phytoestrogens: a review of the evidence. Maturitas, 42, 173-185 (2002).
3. Setchell, K. D. R., Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflaovnes. Am. J. Clin. Nutr., 68, 1333S-1346S (1998).
4. Nurmi, T., Mazur, W., Heinonen, S., Kokkonen, J., and Adlercreutz, H., Isoflavone content of the soy based supplements. J. Pharm. Biomed. Anal., 28, 1-11 (2002).
5. Pascual-Teresa, S. D., Hallund, J., Talbot, D., Schroot, J., Williams, C. M., Bugel, S., and Cassidy, A., Absorption of isoflavones in humans: effects of food matrix and processing. J. Nutr. Biochem., 17, 257-264 (2006).
6. Jou, H. J., Ling, P. Y., and Wu, S. C., Comparison of 70 mg and 35 mg isoflavone soya supplement for menopause symptoms. Int. J. Gyneco. Obstet., 90, 159-160 (2005).
7. Han, K. K., Soares, J. M., Haidar, M. A., Lima, G. R., and Baracat, E. C., Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol., 99, 389-394 (2002).
8. Potter, S. M., Baum, J. A., Teng, H., Stillman, R. J., Shay, N. F., and Erdman Jr., J. W., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr., 68, 1375S-1379S (1998).
9. Peeters, P. H. M., Keinan-Boker, L., Van Der Schouw, Y. T., and Grobbee, D. E., Phytoestrogens and breast cancer risk. Breast Cancer Res. Treat., 77, 171-183 (2003).
10. Kumar, N. B., Cantor, A., Allen, K., Riccard, D., Besterman-Dahan, K., Seigne, J., Helal, M., Salup, R., and Pow-Sang, J., The specific role of isoflavones in reducing prostate cancer risk. Prostate, 59, 141-147 (2004).
11. Buvari-Barcza, A., and Barcza, L., Changes in the solubility of β-cyclodextrin on complex formation: guest enforced solubility of β-cyclodextrin inclusion complexes. J. Inclusion Phenomena Macrocyclic Chem., 36, 355-370 (2000).
12. Martin Del Valle, E. M., Cyclodextrins and their uses: a review. Pro. Biochem., 39, 1033-1046 (2003).
13. Szejtli, J., Introduction and general overview of cyclodextrin chemistry. Chem. Rev., 98, 1743-1753 (1998).
14. Hedges, A. R., Industrial applications of cyclodextrins. Chem. Rev., 98, 2035-2044 (1998).
15. Hirayama, F., and Uekama, K., Cyclodextrin-based controlled drug release system. Adv. Drug Deliv. Rev., 36, 125-141 (1999).
16. Tamura, M., Effect of intestinal flora on the metabolism and absorption of isoflavones. JARQ, 40, 45-50 (2006).
17. Heinonen, S. M., Wahala, K., and Adlercreutz, H., Metabolism of isoflavones in human subjects. Phytochem. Rev., 1, 175-182 (2002).
18. Hur, H. G., Lay Jr., J. O., Beger, R. D., Freeman, J. P., and Rafii, F., Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch. Microbiol., 174, 422-428 (2001).
19. Piskula, M. K., Yamakoshi, J., and Iwai, Y., Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett., 447, 287-291 (1999).
20. Hendrich, S., Bioavailability of isoflavones. J. Chromatogr. B, 777, 203-210 (2002).
21. Xu, X., Wang, H. J., Murphy, P. A., and Cook, L., Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr., 124, 825-831 (1994).
22. Izumi, T., Piskula, M. K., Osawa, S., Obata, A., Tobe, K., Saito, M., Kataoka, S., Kubota, Y., and Kikuchi, M., Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr., 130, 1695-1699 (2000).
23. Setchell, K. D. R., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., Kirschner, A. S., Cassidy, A., and Heubi, J. E., Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavnone supplements. J. Nutr., 131, 1362S-1375S (2001).
24. Bowey, E., Adlercreutz, H., and Rowland, I., Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem. Toxicol., 41, 631-636 (2003).
25. Muthyala, S. R., Ju, Y. H., Sheng, S., Williams, L. D., Doerge, D. R., Katzenellenbogen, B. S., Helferichb, W. G., and Katzenellenbogen, J. A., Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med. Chem., 12, 1559-1567 (2004).
26. Zubik, L., and Meydani, M., Bioavailability of soybean isoflavones from aglycone and glucoside form in American women. Am. J. Clin. Nutr., 77, 1459-1465 (2003).
27. Choi, Y. B., Rhee, J. S., Lee, Y. B., Nam, S. Y., and Kim, K. S., Extraction of isoflavones from soybean hypocotyls using aqueous ethanol. Food Sci. Biotechnol., 13, 719-723 (2004).
28. Higuchi, T., and Connors, K. A., A phase solubility technique. Adv. Anal. Chem. Instrum. (New York), 4, 117-211 (1965).
29. Griffith, A. P., and Collison, M. W., Improved methods for the extraction and analysis of isoflavones from soy-containing foods and nutritional supplements by reversed-phase high-performance liquid chromatography and liquid chromatography-mass spectrometry. J. Chromatogr. A, 913, 397-413 (2001).
30. Kriz, Z., Koca, J., Imberty, A., Charlot, A., and Auzely-Velty, R., Investigation of the complexation of (+)-catechin by β-cyclodextrin by a combination of NMR, microcalorimetry and molecular modeling techniques. Org. Biomol. Chem., 1, 2590-2595 (2003).
31. Holder, C. L., Churchwell, M. I., and Doerge, D. R., Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. J. Agric. Food Chem., 47, 3764-3770 (1999).
32. Zhang, Y., Hendrich, S., and Murphy, P. A., Glucuronides are the main isoflavone metabolites in women. J. Nutr., 133, 399-404 (2003).
33. Suzuki, T., Matsuzaki, T., Hagiwara, H., Aoki, T., Tajika-Takahashi, Y., and Takata, K., Apical localization of sodium-dependent glucose transporter SGLT1 is maintained by cholesterol and microtubules. Acta Histochem. Cytochem., 39, 155-161 (2006).